Tag: Kaléo

Auvi-Q

FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants...

The new epinephrine auto-injector would feature a lower dose and shorter needle length suitable for smaller children.
Kaleo Booth

Auvi-Q Takes Center Stage at School Nurse Conference

One example of the changing market dynamics for epinephrine auto-injectors in light of recent developments.
Symjepi™ Prefilled Syringe

Welcome Symjepi™: Adamis' Prefilled Epinephrine Syringe Receives FDA Approval

The additional competition should help lower costs across the emergency epinephrine market.
Kaleo Evzio

Kaléo Sued Over Evzio, an Auto-Injector With Pricing Structure Similar to...

Arcane system of pricing and insurance rebates at heart of the suit.
Sanofi

Sanofi Files Suit Against Mylan for Anti-Competitive EpiPen Strategy

More legal troubles for the embattled marketer of EpiPen.
Kmart

Kmart Announces Lower Price of Adrenaclick Generic

May cost as low as $0 to consumers with commercial health insurance.
Senator Claire McCaskill

Senators Inquire into Kaléo Pricing

Pricing for their Evzio naloxone auto-injector is similar to that of their recently relaunched Auvi-Q epinephrine auto-injector.

Auvi-Q Goes On Sale Today with a Bold Pricing and Distribution...

Innovation and participation by insurers will be key to the successful reintroduction of the device.

Auvi-Q and the $4500 Question

Will kaleó succeed in providing an affordable auto-injector alternative to families in desperate need?
Auvi-Q

Kaleo Takes a Bold Step as Auvi-Q Returns

The company pledges $0 out-of-pocket expenses for many when the auto-injector is reintroduced February 14. FAQ included in article.